Oxygen Therapy Device Market Summary
As per MRFR Analysis, the Oxygen Therapy Device Market was valued at 3.15 USD Billion in 2023 and is projected to grow to 5 USD Billion by 2035, with a CAGR of 3.93% from 2025 to 2035. The market is driven by the rising incidence of respiratory diseases, an aging population, and technological advancements in oxygen delivery systems.
Key Market Trends & Highlights
The Global Oxygen Therapy Device Market is experiencing significant trends that are reshaping its landscape.
- The market is expected to reach 3.27 USD Billion in 2024, driven by increasing respiratory conditions.
- Oxygen Concentrators are projected to dominate the market with a valuation of 1.25 USD Billion in 2024.
- The aging population is expected to reach 2 billion by 2050, increasing the demand for oxygen therapy.
- Technological advancements are enhancing device efficiency, with Continuous Flow and Pulse Dose Technologies gaining traction.
Market Size & Forecast
2023 Market Size: USD 3.15 Billion
2024 Market Size: USD 3.27 Billion
2035 Market Size: USD 5.0 Billion
CAGR (2025-2035): 3.93%
Largest Regional Market Share in 2024: North America.
Major Players
Key players include AirSep Corporation, Fisher and Paykel Healthcare, Invacare, OxyGo, GCE Group, NIDEK, ResMed, Philips, DeVilbiss Healthcare, Vyaire Medical, Breas Medical, Medtronic, Becton Dickinson, Apex Medical, and Smiths Medical.
Key Oxygen Therapy Device Market Trends Highlighted
The Oxygen Therapy Device Market is witnessing significant trends influenced by various factors. An increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, is a major market driver. This growing incidence is largely attributed to factors like pollution, smoking, and aging populations, particularly in urban areas across various countries. As public awareness about respiratory health improves, demand for oxygen therapy devices continues to rise, leading to a surge in product innovation and technology advancements. Opportunities in the market are abundant, particularly with the rise of home healthcare and increasing acceptance of home-based oxygen therapy.
Telemedicine and remote monitoring have come a long way, and now healthcare providers can better manage patient care while allowing people to live better lives at home. It's also important to make oxygen systems that are portable and light, so that patients who want to be able to move around and be independent can use them. Manufacturers should think about working with tech companies to add connectivity features to their devices that will make them more useful. Recent trends show that more and more people are using digital solutions that work with oxygen therapy devices. This includes mobile apps that help keep track of how often patients use them and plan their therapy sessions.
Additionally, awareness campaigns initiated by health authorities and organizations emphasize the importance of early diagnosis and preventive care for respiratory conditions. This drives growth in the market as patients become more proactive in seeking treatment options. Overall, the Oxygen Therapy Device Market is evolving rapidly, propelled by a combination of rising health awareness, technological advancements, and shifts in healthcare delivery models.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Oxygen Therapy Device Market Drivers
Rising Incidence of Respiratory Disorders
The Oxygen Therapy Device Market is experiencing robust growth due to the increasing prevalence of respiratory disorders such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and pneumonia. According to the World Health Organization (WHO), COPD is projected to be the third leading cause of death globally by 2030, with an expected increase of approximately 2.4 million deaths per year. This significant health crisis amplifies the demand for oxygen therapy devices, as patients require supplemental oxygen for effective management of their conditions.
Major organizations, like the Centers for Disease Control and Prevention (CDC), report that over 16 million Americans are living with diagnosed COPD, indicating a substantial market presence. With such alarming statistics and the expanding aging population, the Oxygen Therapy Device Market is set for accelerated growth as healthcare providers focus on ensuring greater access to these essential therapeutic devices.
Technological Advancements in Oxygen Therapy Devices
Advancements in technology have significantly influenced the Oxygen Therapy Device Market, making devices more efficient and patient-friendly. Innovations such as portable oxygen concentrators and improved delivery systems have enhanced patient mobility and ease of use. For example, the introduction of smart oxygen therapy devices that monitor oxygen levels and provide real-time feedback is gaining traction. The U.S. Food and Drug Administration (FDA) has been proactive in approving several new devices aimed at improving patient outcomes, creating a competitive edge for manufacturers.
As a result, the market is witnessing an increasing adoption of these advanced devices, catering to a growing customer base that seeks reliability and convenience.
Increase in Global Geriatric Population
The Oxygen Therapy Device Market is poised for growth due to the aging global population that often suffers from age-related illnesses, including respiratory conditions. The United Nations reports that the number of people aged 65 years or older is expected to increase from 703 million in 2019 to 1.5 billion by 2050. This demographic shift necessitates greater access to healthcare solutions, including oxygen therapy devices, designed to improve the quality of life for elderly patients.
Countries like Japan, which have the highest percentage of elderly individuals, are witnessing a surge in demand for these devices to manage chronic respiratory illnesses effectively. Therefore, industry stakeholders are focusing on developing tailored therapies that cater to this vulnerable population.
Government Initiatives and Support
Supportive government initiatives and funding for respiratory care are accelerating the growth of the Oxygen Therapy Device Market. Various governments worldwide are recognizing the significance of respiratory health and have initiated programs aimed at increasing accessibility to oxygen therapy devices. For example, recent policies have been introduced in several countries to improve health insurance coverage for respiratory conditions, which has proven to increase the use of oxygen therapy.
Furthermore, public health campaigns aimed at raising awareness, highlighting the importance of oxygen therapy for chronic patients, are boosting market expansion. This engagement not only helps in increasing the acceptance of oxygen devices but also encourages further Research and Development (R&D) in the field.
Oxygen Therapy Device Market Segment Insights
Oxygen Therapy Device Market Type Insights
The Oxygen Therapy Device Market is experiencing steady growth and segmentation based on various types, which include Oxygen Concentrators, Liquid Oxygen Systems, Oxygen Cylinders, Portable Oxygen Devices, and Oxygen Accessories. In 2024, the market is projected to reach a valuation of 3.27 USD billion, with Oxygen Concentrators being the most significant segment, valued at 1.3 USD Billion, thus holding a majority share in the market. By 2035, the overall market is expected to grow to 5.0 USD billion, reflecting a broader trend towards home-based and portable oxygen support systems. The Oxygen Concentrators segment is particularly important due to its efficiency and ease of use, catering to a large number of patients with chronic respiratory conditions. Following this, Liquid Oxygen Systems, valued at 0.75 USD billion in 2024 and projected to grow to 1.2 USD billion by 2035, are also gaining traction, providing a compact option for patients needing oxygen therapy.
On the other hand, the Oxygen Cylinders segment is valued at 0.65 USD Billion in 2024, showing steady demand, especially in emergency medical situations, which remains essential for hospitals and rescue services. The market for Portable Oxygen Devices, valued at 0.4 USD Billion in 2024, is gaining popularity among patients requiring mobility, indicating a growing trend towards portable solutions for oxygen delivery. These devices are particularly significant as they enable greater mobility for patients, allowing them to maintain a more active lifestyle while receiving necessary therapy.Â
Lastly, the Oxygen Accessories segment, though smaller with a valuation of 0.17 USD Billion in 2024, plays a crucial role in the overall support ecosystem for oxygen therapy, including tubing, masks, and regulators, and is projected to see growth to 0.2 USD Billion by 2035. This segmented analysis of the Oxygen Therapy Device Market illustrates a comprehensive understanding of its various components, reflecting ongoing trends and the importance of offering diverse options for patients in need of oxygen therapy, while facilitating a clearer picture of market dynamics and potential for future developments.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Oxygen Therapy Device Market Application Insights
The Oxygen Therapy Device Market focuses significantly on various applications, with Chronic Obstructive Pulmonary Disease, Asthma, Respiratory Distress Syndrome, Sleep Apnea, and Cystic Fibrosis being crucial areas. Among these, Chronic Obstructive Pulmonary Disease (COPD) is a leading factor, as it contributes to numerous hospital admissions worldwide, thus driving the demand for oxygen therapy devices. Asthma is another prevalent condition, impacting millions globally, which has furthered the need for effective oxygen therapy solutions.
Respiratory Distress Syndrome, particularly in neonatal cases, continues to raise awareness and augment device usage within hospital settings. Similarly, Sleep Apnea has gained prominence as more individuals seek treatments for disrupted sleep patterns, contributing to the market's growth. Cystic Fibrosis patients heavily rely on oxygen therapy devices, with advancements in technology enhancing their quality of life. Collectively, these applications shape the Oxygen Therapy Device Market segmentation, demonstrating the diversified needs and compelling reasons for market growth driven by critical respiratory health challenges.
Oxygen Therapy Device Market End Use Insights
The Oxygen Therapy Device Market has showcased substantial growth, projected to reach a valuation of 3.27 USD billion by 2024. Within the realm of End Use, the market is characterized by diverse applications in various settings. Hospitals represent a key sector, driven by the rising prevalence of respiratory disorders and the need for emergency interventions. Home Care Settings have also gained prominence, as patients prefer receiving treatment in a familiar environment, leading to increased demand for portable devices. Emergency Medical Services are critical, catering to urgent requirements for oxygen supply during crises, ensuring quick response and patient stabilization.
Long-term Care Facilities have seen a significant increase in oxygen therapy usage, addressing chronic conditions among the aging population. This growing interest highlights the importance of oxygen therapy devices in enhancing patient outcomes across multiple environments, ultimately contributing to the overall market growth and shaped by factors such as technological advancements and evolving healthcare policies. The segmentation of the Oxygen Therapy Device Market provides insight into its revenue potential, helping stakeholders to explore opportunities for innovation and expanded services in this essential healthcare field.
Oxygen Therapy Device Market Technology Insights
The Oxygen Therapy Device Market is a rapidly evolving segment within the healthcare industry, projected to reach a valuation of 3.27 billion USD in 2024, with a robust expected growth trajectory. The Technology aspect encompasses various methodologies, notably Continuous Flow Technology, Pulse Dose Technology, and Hybrid Oxygen Therapy. Continuous Flow Technology provides a consistent supply of oxygen, making it essential for patients requiring long-term treatment and enabling improved mobility and quality of life. Conversely, Pulse Dose Technology offers more efficiency by delivering oxygen in bursts, which is particularly beneficial for patients with periodic respiratory needs.
Hybrid Oxygen Therapy combines the advantages of both continuous and pulse modes, thereby addressing a broader range of patient requirements. It is significant in real-world applications as it enhances patient comfort and compliance. Driving factors for market growth include the rising prevalence of respiratory diseases and an increasing aging population, while challenges such as high costs and equipment maintenance may impact accessibility. Overall, the Oxygen Therapy Device Market continues to expand, supported by advancements in technology and a clear need for improved therapeutic solutions.
Oxygen Therapy Device Market Regional Insights
The Regional analysis of the Oxygen Therapy Device Market reveals significant insights across various areas. In 2024, North America is projected to hold a majority share with a valuation of 1.25 USD Billion, growing to 1.85 USD billion by 2035, demonstrating its prominence due to advanced healthcare infrastructure and rising chronic respiratory diseases. Europe follows, valued at 0.85 USD billion in 2024, indicating a robust market fueled by an increasing aging population and health awareness, and is expected to reach 1.25 USD billion by 2035.
The Asia Pacific region, with a valuation of 0.7 USD Billion in 2024, is critical as it reveals significant growth potential, anticipated to expand to 1.0 USD billion in 2035 due to rising air pollution and deteriorating health conditions. South America, valued at 0.3 USD Billion in 2024, indicates a developing market that is expected to improve to 0.5 USD billion by 2035, driven by expanding healthcare access. The Middle East and Africa stand as the smallest segment, with a market value of 0.17 USD billion in 2024, which may rise to 0.4 USD billion by 2035, generating opportunities due to increasing healthcare investments and awareness.
Overall, the segmentation of the Oxygen Therapy Device Market reveals diverse factors fueling growth and outlining the importance of regional trends in addressing respiratory health.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Oxygen Therapy Device Market Key Players and Competitive Insights
The Oxygen Therapy Device Market has been experiencing a notable transformation driven by advancements in technology, increasing prevalence of respiratory diseases, and a growing geriatric population. The competitive landscape of this market is characterized by the presence of various key players who are focused on innovating and expanding their product lines to meet the evolving needs of patients and healthcare providers. Companies invest substantially in research and development to create advanced devices that enhance patient comfort, improve efficiency, and offer greater portability. As a result, the market has become increasingly segmented, with players exploring niche markets such as home care and portable oxygen solutions to capture a larger share. The dynamics of this market are influenced by factors such as regulatory approvals, reimbursement policies, and strategic partnerships that help in expanding geographical presence.
Invacare has established itself as a leading entity within the Oxygen Therapy Device Market due to its extensive product portfolio and robust market presence. The company's strengths lie in its strong brand recognition and commitment to delivering high-quality oxygen therapy solutions for home healthcare settings. Invacare offers a range of oxygen products, including stationary and portable concentrators, which are widely accepted by healthcare providers and patients alike. The company has a broad distribution network, enabling it to cater to diverse markets across the globe. Its focus on user-friendly designs and technological innovations helps increase patient adherence and satisfaction, contributing to its competitive edge in the market. Invacare's consistent investment in enhancing its product features, such as noise reduction and portability, further solidifies its position as a leader in the oxygen therapy segment.
O2 Concepts is another prominent player in the Oxygen Therapy Device Market, recognized for its advancements in portable oxygen solutions. The company specializes in manufacturing lightweight and user-friendly oxygen concentrators that have garnered considerable attention from both patients and healthcare professionals. O2 Concepts prioritizes innovation, resulting in products designed to provide an optimal balance of mobility and therapeutic effectiveness.Â
The company has developed a range of portable devices that cater to the needs of an active lifestyle, which distinguishes it within the marketplace. In recent years, O2 Concepts has expanded its market presence through strategic partnerships and collaborative initiatives, enhancing its reach and distribution capabilities. The company is committed to improving healthcare outcomes and fostering patient independence by offering superior oxygen therapy options. O2 Concepts continues to focus on growth strategies, including mergers and acquisitions, to further solidify its market footprint and adapt to the changing demands of the global healthcare ecosystem.
Key Companies in the Oxygen Therapy Device Market Include:
- Invacare
- O2 Concepts
- Breas Medical
- Fisher & Paykel Healthcare
- DeVilbiss Healthcare
- Drive Medical
- Getinge
- Medtronic
- Philips
- GCE Healthcare
- AirSep
- Nidek Medical Products
- Inogen
- ResMed
Oxygen Therapy Device Market Developments
Recent changes in the Oxygen Therapy Device Market have shown that things are getting better because more people need respiratory care devices because of chronic diseases and an aging population. Philips talked about improvements in its home oxygen concentrator line in September 2023, focusing on how easy they are to move and how well patients follow the rules. ResMed also had a good third quarter in 2023, saying that its growing respiratory care portfolio was responsible for the growth. As of August 2023, Inogen, a major player in portable oxygen concentrators, continued to gain market share with new products aimed at patients who can walk.Â
There hasn't been an official announcement of an acquisition yet, but rumors of closer cooperation between companies like Breas Medical and Nidek Medical Products have made the competitive landscape more interesting. In July 2023, Masimo showed off improvements to its respiratory monitoring technologies, which made them work better with oxygen delivery systems.Â
The market has also benefited from changing rules, especially in the U.S. and Europe, which have made it easier for new oxygen delivery devices to get approved faster. These changes show that the market is moving toward more personalized, home-based oxygen therapy, which will lead to more growth in the future.
Oxygen Therapy Device Market Segmentation Insights
Oxygen Therapy Device Market Type Outlook
- Oxygen Concentrators
- Liquid Oxygen Systems
- Oxygen Cylinders
- Portable Oxygen Devices
- Oxygen Accessories
Oxygen Therapy Device Market Application Outlook
- Chronic Obstructive Pulmonary Disease
- Asthma
- Respiratory Distress Syndrome
- Sleep Apnea
- Cystic Fibrosis
Oxygen Therapy Device Market End Use Outlook
- Hospitals
- Home Care Settings
- Emergency Medical Services
- Long-term Care Facilities
Oxygen Therapy Device Market Technology Outlook
- Continuous Flow Technology
- Pulse Dose Technology
- Hybrid Oxygen Therapy
Oxygen Therapy Device Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
|
Report Attribute/Metric
|
Details
|
|
Market Size 2023
|
3.15 (USD Billion)
|
|
Market Size 2024
|
3.27 (USD Billion)
|
|
Market Size 2035
|
5.0 (USD Billion)
|
|
Compound Annual Growth Rate (CAGR)
|
3.94% (2025 - 2035)
|
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
|
Base Year
|
2024
|
|
Market Forecast Period
|
2025 - 2035
|
|
Historical Data
|
2019 - 2024
|
|
Market Forecast Units
|
USD Billion
|
|
Key Companies Profiled
|
Invacare, O2 Concepts, Breas Medical, Fisher & Paykel Healthcare, DeVilbiss Healthcare, Drive Medical, Getinge, Medtronic, Philips, GCE Healthcare, AirSep, Nidek Medical Products, Inogen, ResMed
|
|
Segments Covered
|
Type, Application, End Use, Technology, Regional
|
|
Key Market Opportunities
|
Aging population driving demand, Technological advancements in devices, Increasing prevalence of respiratory disorders, Growing home healthcare market, Rising awareness of oxygen therapies.
|
|
Key Market Dynamics
|
rising prevalence of respiratory diseases, increasing geriatric population, technological advancements in devices, growing awareness and adoption, expanding home healthcare market
|
|
Countries Covered
|
North America, Europe, APAC, South America, MEA
|
Oxygen Therapy Device Market Highlights:
Frequently Asked Questions (FAQ) :
The Oxygen Therapy Device Market is expected to be valued at 3.27 billion USD in 2024.
By 2035, the Oxygen Therapy Device Market is projected to reach 5.0 billion USD.
The Oxygen Therapy Device Market is expected to grow at a CAGR of 3.94% during the period from 2025 to 2035.
North America is expected to hold the largest market share, valued at 1.85 billion USD by 2035.
Oxygen Concentrators are valued at 1.3 billion USD in 2024 and expected to reach 2.0 billion USD by 2035.
Key players include Invacare, O2 Concepts, Breas Medical, Fisher & Paykel Healthcare, and Medtronic, among others.
The market value for Liquid Oxygen Systems is expected to be 0.75 billion USD in 2024 and 1.2 billion USD by 2035.
By 2035, the market for Portable Oxygen Devices is projected to be valued at 0.7 billion USD.
Emerging trends such as technological advancements and the increasing prevalence of respiratory diseases are driving market growth.
In Europe, the Oxygen Therapy Device Market is expected to be valued at 1.25 billion USD by 2035.
